{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001146112.2:c.137G>A",
          "cDNA Change": {
            "transcript": "NM_001146112.2",
            "ref": "G",
            "alt": "A",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "Mutation E46K"
        },
        {
          "HGVS": "NM_001146112.2:c.90C>T",
          "cDNA Change": {
            "transcript": "NM_001146112.2",
            "ref": "C",
            "alt": "T",
            "position": "90"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "V",
            "position": "30"
          },
          "Description in input context": "Mutation A30P"
        },
        {
          "HGVS": "NM_001146112.2:c.158G>A",
          "cDNA Change": {
            "transcript": "NM_001146112.2",
            "ref": "G",
            "alt": "A",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "Mutation A53T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Dementia with Lewy bodies",
    "MONDO": "MONDO:0005273"
  },
  "Experiment Method": [
    {
      "Assay Method": "Liposome pull-down assay",
      "Material used": {
        "Material Source": "Artificial liposomes",
        "Material Name": "PC/PS/cholesterol liposomes",
        "Description": "Liposomes of two different compositions (A and B) were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001146112.2:c.137G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "increased binding",
          "Result Description": "Mutation E46K increased the binding of a-synuclein to type A liposomes by 88% and to type B liposomes by 56%."
        },
        {
          "Variant": "NM_001146112.2:c.90C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "decreased binding",
          "Result Description": "Mutation A30P reduced the binding of a-synuclein to type A liposomes by 95% and to type B liposomes by 53%."
        },
        {
          "Variant": "NM_001146112.2:c.158G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "no significant effect",
          "Result Description": "Mutation A53T led to a non-significant 9–12% reduction in the binding of a-synuclein to both liposome types."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "The measurements were obtained from three independent protein preparations, each run in duplicate."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each independent protein preparation was run in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type a-synuclein was used as a control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "GST bound to glutathione–agarose was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Data are expressed as means ± S.E.M."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Filament assembly assay",
      "Material used": {
        "Material Source": "Recombinant human a-synucleins",
        "Material Name": "wild-type and mutant a-synucleins",
        "Description": "Assembly of a-synuclein proteins was monitored quantitatively by ThT fluorescence and semi-quantitatively by electron microscopy."
      },
      "Readout type": "Quantitative and Semi-quantitative",
      "Readout description": [
        {
          "Variant": "NM_001146112.2:c.137G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "increased assembly",
          "Result Description": "E46K a-synuclein showed a faster rate of assembly and a 2.5-fold greater total assembly than the wild-type protein at 98 h."
        },
        {
          "Variant": "NM_001146112.2:c.90C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "decreased assembly rate",
          "Result Description": "The rate of assembly of the A30P mutant was slower than for wild-type a-synuclein, but the amount of assembly was similar to that of the E46K and A53T mutants at 98 h."
        },
        {
          "Variant": "NM_001146112.2:c.158G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "increased assembly",
          "Result Description": "The A53T mutant behaved in a similar way to E46K a-synuclein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "The measurements were obtained from three independent protein preparations."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each independent protein preparation was run in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type a-synuclein was used as a control."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Data are expressed as means ± S.E.M."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}